Publications by authors named "Madison Ellis"

Claim this Profile
M
Monocyte-eosinophil signaling axis promotes vaccine-mediated protection against SARS-CoV-2.
Kathryn M Moore, Stephanie L Foster, Meenakshi Kar, Katharine A Floyd, Elizabeth J Elrod, Madison Ellis

PLoS Pathog· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins.
Sanjeev Kumar, Shilpi Jain, Bushra Wali, Veronika I Zarnitsyna, Devyani Joshi, Madison L Ellis

Sci Transl Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caring for the LGBTQIA+ Patient: A Best-Practices Primer on Language, Sexual Function Considerations, and Health Disparities in Gynecologic Care.
Molly K Irvin, Madison Ellis, Tierney K Lorenz

J Minim Invasive Gynecol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk.
Mallory C Shriver, Patricia L Milletich, Alberto Moreno, Sasha E Larsen, Christine M Posavad, Madison Ellis

Pathog Immun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant.
Mehul S Suthar, Kelly E Manning, Madison L Ellis, Shilpi Jain, Kareem Bechnak

Lancet Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.
Matthew Gagne, Barbara J Flynn, Shayne F Andrew, Josue Marquez, Dillon R Flebbe, Madison Ellis

Nat Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity.
Alberto Moreno, Kelly Manning, Maryam I Azeem, Ajay K Nooka, Madison Ellis

NPJ Vaccines· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity.
Martin C Runnstrom, Pedro A Lamothe, Caterina E Faliti, Narayanaiah Cheedarla, Alberto Moreno, Madison L Ellis

J Allergy Clin Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophils protect against SARS-CoV-2 following a vaccine breakthrough infection.
Kathryn M Moore, Stephanie L Foster, Meenakshi Kar, Katharine A Floyd, Elizabeth J Elrod, Madison Ellis

bioRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.
Barbara Mühlemann, Samuel H Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Madison Ellis

Sci Transl Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans.
Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci, Lilin Lai, Bushra Wali, Madison Ellis

Sci Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants.
Shilpi Jain, Sanjeev Kumar, Lilin Lai, Susanne Linderman, Ansa A Malik, Madison L Ellis

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates.
Matthew Gagne, Barbara J Flynn, Shayne F Andrew, Dillon R Flebbe, Anna Mychalowych, Madison Ellis

bioRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term biodegradation of crude oil in high-arctic backshore sediments: The Baffin Island Oil Spill (BIOS) after nearly four decades.
Lars Schreiber, Blake Hunnie, Ianina Altshuler, Esteban Góngora, Madison Ellis

Environ Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity.
Alberto Moreno, Kelly Manning, Maryam I Azeem, Ajay K Nooka, Madison Ellis

Res Sq· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.
Barbara Mühlemann, Samuel H Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Madison Ellis

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity.
Alberto Moreno, Kelly Manning, Maryam I Azeem, Ajay K Nooka, Madison Ellis

bioRxiv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.
Andres Chang, Jean L Koff, Lilin Lai, Victor M Orellana-Noia, Minal Surati, Madison L Ellis

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of immune responses to mRNA booster vaccination against COVID-19.
Prabhu S Arunachalam, Lilin Lai, Hady Samaha, Yupeng Feng, Mengyun Hu, Madison Ellis

J Clin Invest· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections.
Maryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Madison Leigh Ellis

Blood Cancer Discov· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of immune responses to the booster mRNA vaccination against COVID-19.
Prabhu S Arunachalam, Lilin Lai, Hady Samaha, Yupeng Feng, Mengyun Hu, Madison Ellis

medRxiv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.
Rajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, Akil Akthar, Ralph Linwood Millett, Madison Ellis

J Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
Sneh Lata Gupta, Grace Mantus, Kelly E Manning, Madison Ellis, Mit Patel

J Virol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron.
Matthew Gagne, Juan I Moliva, Kathryn E Foulds, Shayne F Andrew, Barbara J Flynn, Madison Ellis

Cell· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination.
Grace Mantus, Lindsay E Nyhoff, Venkata-Viswanadh Edara, Veronika I Zarnitsyna, Caroline R Ciric, Madison Ellis

Cell Rep Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis